First Episealer® surgery planned in India

Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery in India with the knee implant Episealer® has been scheduled.

India presents a unique opportunity to enter a vast market with the Episealer® technology. Episurf Medical has worked closely with Prof. Niek van Dijk and Prof. Doctor João Espregueira-Mendes who have aided in introducing local orthopaedic surgeons to the Episealer® technology. Both are advisors to Episurf Medical.

“We are now offering the Episealer® technology to our Indian customers, and we are pleased with having the first surgery in India scheduled. Before the pandemic, we had a clear focus on this market, but naturally, we had to more or less stop the activities for a while. However, now activities have started again, this is an important milestone for us. The Indian market represents a significant opportunity for us, and as we take our first steps here, we are already structuring plans to scale up in this important market”, says Pål Ryfors, CEO Episurf Medical.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Tags: